Alnylam Pharmaceuticals (ALNY)
Alnylam Pharmaceuticals Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -11.37M | -14.30M | -13.24M | -13.82M | -16.28M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 2.121M | 1.237M | 1.262M | 1.287M | 1.339M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 3.966M | 5.251M | 5.439M | 5.362M | 5.332M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 6.087M | 6.488M | 6.701M | 6.649M | 6.671M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 10.67M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Changes in Assets/Liabilities | -24.93M | -17.34M | -22.49M | -19.40M | 3.309M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | -30.22M | -25.16M | -29.02M | -26.58M | -6.305M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.263M | -0.524M | -0.265M | -0.474M | -0.028M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | -65.17M | 21.31M | 36.52M | 3.111M | 22.32M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | -0.162M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | -65.59M | 20.78M | 36.25M | 2.637M | 22.29M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity Issued | 87.32M | 0.267M | 0.00 | 0.462M | 0.009M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Financing Activities | 87.32M | 0.267M | 0.00 | 0.462M | 0.009M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Net Change in Cash & Cash Equivalents | -8.489M | -4.108M | 7.226M | -23.48M | 15.99M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 70.23M | 74.60M | 70.23M | 74.34M | 67.11M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 61.74M | 70.23M | 74.34M | 67.11M | 90.59M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
